Syncozymes's annual production of 100 tons of coenzyme NMN/NADH/NAD series products will be officially put into production in October this year!
(Zhejiang Syncozymes Bio-pharmaceutical Co., Ltd.)
As the forerunner of domestic green biological enzyme catalysis technology, Syncozymes has invested 2 billion yuan in the "Bio-enzyme series products and chemical drug industry" on the basis of integrating the R&D and production advantages of the two major companies, Shangke (Shanghai) Biology and Supor Pharmaceuticals. the chemical based project is progressing.
Post time: Aug-03-2022